CUE
Cue Biopharma, Inc.Company with tickers: CUE
CIK
1645460
CUSIP
22978P106
Shares Outstanding
4,045,701
Price History
Institutional Holders
Short Volume
Short Interest
Fails to Deliver
Financials
SEC Filings
Earnings Calls
Insider Trades
Congressional Trades
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | $5,686,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | $11,039,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Research & Development | $6,897,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Operating Income | $-5,353,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| Net Income | $-5,178,000 | USD | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Basic) | $-1.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |
| EPS (Diluted) | $-1.08 | USD/shares | 2026-03-31 | 10-Q | 2026-05-14 |